Study is to characterize the safety and tolerability of cefazolin after a single IV
administration in healthy subjects in a 3 g/150 mL presentation to meet the increasing
clinical need for the indication of perioperative prophylaxis in this patient population
weighing greater than or equal to (≥) 120 kg.